283 related articles for article (PubMed ID: 26489635)
21. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review.
Sun LM; Xu Y; Xu MN; Wang M; Su Y; Yuan SM
Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110157. PubMed ID: 32544638
[TBL] [Abstract][Full Text] [Related]
22. Propranolol treatment of infantile hemangioma: clinical and radiologic evaluations.
Talaat AA; Elbasiouny MS; Elgendy DS; Elwakil TF
J Pediatr Surg; 2012 Apr; 47(4):707-14. PubMed ID: 22498385
[TBL] [Abstract][Full Text] [Related]
23. β-blockers in the treatment of periocular infantile hemangioma.
Al-Haddad C; El Salloukh NA; El Moussawi Z
Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556
[TBL] [Abstract][Full Text] [Related]
24. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
25. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
26. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
[TBL] [Abstract][Full Text] [Related]
27. Propranolol Use for Infantile Hemangiomas.
Ryan J
Plast Surg Nurs; 2015; 35(3):129-30. PubMed ID: 26313676
[No Abstract] [Full Text] [Related]
28. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
[TBL] [Abstract][Full Text] [Related]
29. Topical propranolol therapy for infantile hemangiomas.
Kunzi-Rapp K
Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
[TBL] [Abstract][Full Text] [Related]
30. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
Mhanna A; Franklin WH; Mancini AJ
Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
[TBL] [Abstract][Full Text] [Related]
31. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
[TBL] [Abstract][Full Text] [Related]
32. [Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences].
Léauté-Labrèze C; Taïeb A
Ann Dermatol Venereol; 2008 Dec; 135(12):860-2. PubMed ID: 19084699
[No Abstract] [Full Text] [Related]
33. Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region.
Sadykov RR; Podmelle F; Sadykov RA; Kasimova KR; Metellmann HR
Int J Oral Maxillofac Surg; 2013 Jul; 42(7):863-7. PubMed ID: 23618833
[TBL] [Abstract][Full Text] [Related]
34. Propranolol in the Treatment of Infantile Hemangiomas: A Meta-Analysis in Chinese Patients.
Li LL; Yan L; Luo MX; Cai YX; Mi XB; Zhang TD
Pediatr Dermatol; 2015; 32(5):e210-4. PubMed ID: 26060892
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial.
Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E
JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828
[TBL] [Abstract][Full Text] [Related]
36. Severe infantile haemangioma: complications and treatment.
Heaton P; Kennedy C; Amin S
J Paediatr Child Health; 2014 Apr; 50(4):325, 330. PubMed ID: 24698064
[No Abstract] [Full Text] [Related]
37. Topical propranolol hydrochloride gel for superficial infantile hemangiomas.
Wang L; Xia Y; Zhai Y; Li C; Li Y
J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):923-926. PubMed ID: 23271298
[TBL] [Abstract][Full Text] [Related]
38. Serum cytokine profiles in infants with infantile hemangiomas on oral propranolol treatment: VEGF and bFGF, potential biomarkers predicting clinical outcomes.
Park M; Jung HL; Shim YJ; Kim HS; Yoon HS; Park SK; Cheuh HW; Lee MJ; Lee JM; Park ES; Lee JH; Lim YJ; Choi YB
Pediatr Res; 2020 Nov; 88(5):749-755. PubMed ID: 32311699
[TBL] [Abstract][Full Text] [Related]
39. Recurrence of infantile hemangiomas treated with propranolol.
Bagazgoitia L; Hernández-Martín Á; Torrelo A
Pediatr Dermatol; 2011; 28(6):658-662. PubMed ID: 22082463
[TBL] [Abstract][Full Text] [Related]
40. Combined low-dose oral propranolol and oral prednisolone as first-line treatment in periocular infantile hemangiomas.
Koay AC; Choo MM; Nathan AM; Omar A; Lim CT
J Ocul Pharmacol Ther; 2011 Jun; 27(3):309-11. PubMed ID: 21542771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
